| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 137.047 | 52.497 | 50.892 | 63.585 | 52.466 | 6.836 | 85.261 | 0 | 0 | - |
| Total Income - EUR | 137.048 | 52.497 | 50.893 | 64.357 | 52.505 | 6.836 | 85.262 | 0 | 0 | - |
| Total Expenses - EUR | 125.643 | 70.547 | 82.896 | 91.193 | 72.794 | 5.384 | 77.069 | 142 | 161 | - |
| Gross Profit/Loss - EUR | 11.405 | -18.050 | -32.003 | -26.836 | -20.289 | 1.452 | 8.193 | -142 | -161 | - |
| Net Profit/Loss - EUR | 9.573 | -18.050 | -32.495 | -27.472 | -20.788 | 1.391 | 5.635 | -142 | -161 | - |
| Employees | 2 | 4 | 3 | 1 | 1 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Biosanmed Partners Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.204 | 3.395 | 3.530 | 56 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 256.545 | 237.467 | 277.592 | 292.704 | 255.229 | 242.668 | 245.120 | 245.891 | 245.146 | - |
| Inventories | 79.695 | 77.932 | 96.227 | 122.515 | 93.882 | 89.467 | 11.081 | 11.115 | 11.082 | - |
| Receivables | 168.888 | 155.371 | 170.599 | 169.578 | 159.535 | 152.015 | 233.611 | 234.336 | 233.626 | - |
| Cash | 7.962 | 4.165 | 10.766 | 611 | 1.800 | 1.176 | 418 | 429 | 429 | - |
| Shareholders Funds | -25.495 | -43.285 | -75.048 | -101.143 | -119.972 | -116.307 | -110.216 | -110.700 | -110.525 | - |
| Social Capital | 51.294 | 50.770 | 49.911 | 48.995 | 48.047 | 47.136 | 46.090 | 46.233 | 46.093 | - |
| Debts | 285.244 | 284.148 | 356.170 | 393.902 | 375.201 | 358.974 | 355.337 | 356.591 | 355.672 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Biosanmed Partners Srl